Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant thymoma.

L S Wang1, M H Huang, T S Lin

  • 1Department of Surgery, Veterans General Hospital, Taipei, Taiwan, Republic of China.

Cancer
|July 15, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[CHK1 attenuates cardiac senescence of mice through activating Rap1/Nox4 mediated oxidative stress homeostasis].

Zhonghua xin xue guan bing za zhi·2025
Same author

[The clinical and imaging presentations of the pontine tegmental cap dysplasia].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2025
Same author

[Research progress on the imaging diagnostic criteria of enlarged vestibular aqueduct].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2025
Same author

[Effect and mechanism of DDX21 on improving myocardial ischemia-reperfusion injury by regulating ATP5J alternative splicing].

Zhonghua xin xue guan bing za zhi·2025
Same author

[Study on the mediating and moderating effects of food intake on blood glucose levels].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2024
Same author

[The imaging appearances of stapical footplate fistula related to inner ear malformation].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2024
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
Same journal

Maintenance therapy in gynecologic malignancies: Current and future state.

Cancer·2026
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
See all related articles

Surgical resection, especially complete thymectomy, followed by radiation is the primary treatment for malignant thymoma. Myasthenia gravis (MG) and tumor stage significantly impact prognosis and treatment outcomes.

Area of Science:

  • Thoracic Surgery
  • Oncology
  • Neurology

Background:

  • Malignant thymoma is a rare tumor with a significant association with myasthenia gravis (MG).
  • Understanding prognostic factors is crucial for effective management.

Purpose of the Study:

  • To analyze the clinical characteristics, treatment outcomes, and prognostic factors of patients with malignant thymoma.
  • To evaluate the role of surgical resection, adjuvant therapies, and patient factors in survival.

Main Methods:

  • Retrospective review of 61 patients with malignant thymoma operated between 1961 and 1989.
  • Analysis of clinical presentation, Masaoka tumor staging, treatment modalities (surgery, radiation, chemotherapy), and survival rates.
  • Correlation of myasthenia gravis (MG) status with treatment and outcomes.

Related Experiment Videos

Main Results:

  • 37.7% of patients had associated myasthenia gravis (MG).
  • Resection rate was 55.7%, with a 1.6% operative mortality. Patients with MG had higher resection and complete thymectomy rates.
  • 5-year and 10-year survival rates were 59% and 34%, respectively. Resectability, adjuvant therapy, MG, and tumor stage influenced prognosis.

Conclusions:

  • Surgical resection, particularly complete thymectomy, followed by irradiation, is the primary therapeutic approach for malignant thymoma.
  • Myasthenia gravis (MG) is a significant comorbidity affecting treatment and outcomes.
  • Tumor staging and resectability are key prognostic indicators for malignant thymoma survival.